Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2012-03-07 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CRECHES-SUR-SAONE (71680), Saone-et-Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES BOUCHARDES : revenue, balance sheet and financial ratios
PHARMACIE DES BOUCHARDES is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CRECHES-SUR-SAONE (71680),
this company of category PME
shows in 2025 a net income positive of 256 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES BOUCHARDES (SIREN 750131542)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
256 399 €
213 504 €
266 441 €
335 546 €
172 288 €
221 065 €
167 608 €
180 980 €
175 934 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DES BOUCHARDES generates positive net income of 256 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 176 k€ -> 256 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
256 399 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 15%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
14.952%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
71.791%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES BOUCHARDES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
134.112
124.594
100.524
76.904
64.399
45.72
35.182
25.377
14.952
Financial autonomy
39.787
40.892
45.941
52.499
56.69
61.673
63.996
67.307
71.791
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
14.952025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-7 pts over 3 years
In 2025, the debt ratio of PHARMACIE DES BOUCHARDES (14.95) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
71.79%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE DES BOUCHARDES (71.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 200.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
200.495
Liquidity indicators evolution PHARMACIE DES BOUCHARDES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
310.286
224.44
268.514
355.003
346.144
309.175
213.098
192.172
200.495
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
200.52025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good
In 2025, the liquidity ratio of PHARMACIE DES BOUCHARDES (200.50) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DES BOUCHARDES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES BOUCHARDES is estimated at
4 072 928 €
(range 2 763 908€ - 6 390 985€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2763k€4072k€6390k€
4 072 928 €Range: 2 763 908€ - 6 390 985€
NAF 5 année 2025
Valuation method used
Net Income Multiple
256 399 €
×
15.9x
=4 072 929 €
Range: 2 763 909€ - 6 390 986€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES BOUCHARDES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES BOUCHARDES
What is the revenue of PHARMACIE DES BOUCHARDES ?
The revenue of PHARMACIE DES BOUCHARDES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES BOUCHARDES profitable?
Yes, PHARMACIE DES BOUCHARDES generated a net profit of 256 k€ in 2025.
Where is the headquarters of PHARMACIE DES BOUCHARDES ?
The headquarters of PHARMACIE DES BOUCHARDES is located in CRECHES-SUR-SAONE (71680), in the department Saone-et-Loire.
Where to find the tax return of PHARMACIE DES BOUCHARDES ?
The tax return of PHARMACIE DES BOUCHARDES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES BOUCHARDES operate?
PHARMACIE DES BOUCHARDES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart